Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Roman Gonec"'
Autor:
Jana Halamkova, Tomas Kazda, Lucie Pehalova, Roman Gonec, Sarka Kozakova, Lucia Bohovicova, Dagmar Adamkova Krakorova, Ondrej Slaby, Regina Demlova, Marek Svoboda, Igor Kiss
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract The prevalence of second primary malignancies (SPMs) in the western world is continually increasing with the risk of a new primary cancer in patients with previously diagnosed carcinoma at about 20%. The aim of this retrospective analysis is
Externí odkaz:
https://doaj.org/article/4fcc073869ee41ac8e20f548ff6856ed
Autor:
Jana Halamkova, Tomas Kazda, Lucie Pehalova, Roman Gonec, Sarka Kozakova, Lucia Bohovicova, Ondrej Slaby, Regina Demlova, Marek Svoboda, Igor Kiss
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
IntroductionAll colorectal cancer (CRC) survivors have an increased risk of developing second primary malignancies (SPMs). The association between diabetes mellitus (DM) and the risk of cancer is well known. However, the role of DM and its therapy in
Externí odkaz:
https://doaj.org/article/cb39fb11acbe4c8e94d1927a67ed0395
The risk of second primary malignancies in colorectal cancer patients using calcium channel blockers
Autor:
Jana Halámková, Lucia Bohovicová, Lucie Pehalová, Tomáš Kazda, Roman Goněc, Teodor Staněk, Lucie Mouková, Dagmar Adámková Krákorová, Šárka Kozáková, Marek Svoboda, Regina Demlová, Lucie Gabrielová, Lenka Hernychová, Igor Kiss
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Calcium channel blockers are among the most commonly used agents in the treatment of cardiovascular diseases. There are several known side-effects associated with their long-term use, whereas other potential adverse effects are yet to be pro
Externí odkaz:
https://doaj.org/article/6d25c6199bb14f1786d61c2c93398684
Autor:
Roman Gonec, Sarka Kozakova
Publikováno v:
Deploying RFID-Challenges, Solutions, and Open Issues
Cytostatics which are drugs used to treat oncologic diseases belong to very dangerous substances. These drugs often have very low therapeutic index, i.e. the difference between therapeutic and toxic dose is very low. Wrong dose can thus endanger the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86a9a0ef54f234c75cef140b10a9f795
http://www.intechopen.com/articles/show/title/rfid-technology-in-preparation-and-administration-of-cytostatic-infusions
http://www.intechopen.com/articles/show/title/rfid-technology-in-preparation-and-administration-of-cytostatic-infusions
